首页> 外国专利> Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof

Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof

机译:评估心脏病毒干预,对治疗的易感性的易感性,死亡率或进一步的心血管事件,以及相关患者的后续肺栓塞的风险,基于GDF-15,Natrietic肽,心肌肌钙蛋白或其组合

摘要

The present invention relates to a method of identifying a subject being susceptible to a cardiac intervention based on the determination of GDF-15 in a sample of a subject in need of a cardiac intervention. Moreover, the present invention pertains to a method for predicting the risk of mortality or a further acute cardiovascular event for a subject suffering from a cardiovascular complication based on the determination of GDF-15 and a natriuretic peptide and/or a cardiac troponin in a sample the said subject. Also encompassed by the present invention are devices and kits for carrying out the aforementioned methods.
机译:本发明涉及鉴定基于需要心脏介入的受试者的样品中的GDF-15易受心脏介入敏感的受试者的方法。 此外,本发明涉及一种用于预测死亡率或进一步急性心血管事件的方法,其基于用于在样品中的GDF-15和Natrietic肽和/或心肌肌钙蛋白的测定中患有心血管复制的受试者 上述主题。 本发明还包括用于执行上述方法的装置和套件。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号